Vaccination Nation: The Not-So-Long Odds Of Long COVID

1A

NPR

News

4.3 • 4.5K Ratings

🗓️ 1 June 2022

⏱️ 32 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Millions of Americans are living with long COVID symptoms.

According to a new report by the CDC, one in five COVID survivors under the age of 65 has experienced a health condition that could be considered long COVID.

For seniors, that number rises to one in four.

We assemble a panel of experts to discuss long COVID and ask listeners to share their experiences.

Want to support 1A? Give to your local public radio station and subscribe to this podcast. Have questions? Find us on Twitter @1A.

Transcript

Click on a timestamp to play from that location

0:00.0	My name is Lindsay and I live in New York. My name is Meredith and I have a son who's 16.
0:13.2	He actually did have lung home COVID. He has it now. I was diagnosed with COVID-19 and subsequently
0:20.5	lung COVID back in early April of 2020. My lung COVID symptoms became very severe about three months
0:28.1	later. He has brain fog, lack of concentration, difficulty sleeping.
0:34.4	The neurologists told us these symptoms could last for six months and they don't know when
0:40.7	it will wane. I really struggled with my breathing and my activity level and I still suffer from
0:47.0	chronic fatigue syndrome. An estimated 40 million Americans traveled over Memorial Day weekend.
0:54.6	Mask mandates on planes, buses and trains are no longer intact. According to Gallup polling data,
1:00.8	one in three Americans believe the pandemic is over. The reality is COVID is still spreading across
1:07.2	the country. The weekly New Case average is roughly 94,000 cases a day but it's more than double
1:13.2	what it was two months ago. Even as New Cases go up, millions are still grappling with the lingering
1:18.8	effects of their old cases. According to the CDC, one in five Americans under 65 who've gotten sick
1:25.4	with COVID have experienced at least one health condition related to long COVID. There are
1:31.0	anti-viral medications. There are anti-viral medications available to treat symptoms but now some
1:38.0	scientists are concerned about their long-term effectiveness. After the break, we'll explore the
1:42.9	challenges of long COVID more than two years into the pandemic. I'm Jen White. You're listening
1:48.6	to the 1A podcast where we get to the heart of the story. And remember to have your questions answered
1:53.6	on future topics or just to let us know what you think. Tweet us at 1A.
2:04.4	We're discussing the challenges of long COVID. Let's get into the conversation.
2:08.6	Joining us now was Dr. Rochelle Walensky, the Director of the Centers for Disease Control and
2:12.9	Prevention. Dr. Walensky, we appreciate you being here. So how concerned should we be
2:18.5	about the rising number of COVID cases across the US and their potential impact on our health care
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from NPR, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of NPR and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.